0.2 |
0.9 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 |
0.4 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 |
0.5 |
GO:0033602 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) |
0.1 |
0.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
0.1 |
0.3 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 |
0.3 |
GO:0002575 |
basophil chemotaxis(GO:0002575) |
0.1 |
0.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 |
0.3 |
GO:0010157 |
response to chlorate(GO:0010157) |
0.1 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
0.1 |
0.2 |
GO:0001552 |
ovarian follicle atresia(GO:0001552) |
0.1 |
0.2 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
0.1 |
0.2 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 |
0.5 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
0.0 |
4.8 |
GO:0009408 |
response to heat(GO:0009408) |
0.0 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
0.0 |
0.1 |
GO:0060024 |
gamma-aminobutyric acid secretion(GO:0014051) calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) rhythmic synaptic transmission(GO:0060024) |
0.0 |
0.2 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 |
0.1 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 |
0.3 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
0.0 |
0.1 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 |
0.1 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 |
0.2 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
0.0 |
0.3 |
GO:0010875 |
positive regulation of cholesterol efflux(GO:0010875) |
0.0 |
0.1 |
GO:0032754 |
positive regulation of interleukin-13 production(GO:0032736) positive regulation of interleukin-5 production(GO:0032754) |
0.0 |
0.1 |
GO:0043501 |
skeletal muscle adaptation(GO:0043501) |
0.0 |
0.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
0.0 |
0.1 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 |
0.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
0.0 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 |
0.1 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
0.0 |
0.4 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
0.0 |
0.7 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
0.0 |
0.3 |
GO:0006400 |
tRNA modification(GO:0006400) |
0.0 |
0.1 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 |
1.3 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
0.0 |
0.0 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.0 |
0.0 |
GO:0035120 |
post-embryonic appendage morphogenesis(GO:0035120) |
0.0 |
0.0 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 |
0.3 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 |
0.1 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
0.0 |
1.0 |
GO:0007498 |
mesoderm development(GO:0007498) |